NCH2 Stock Overview
thyssenkrupp nucera AG & Co. KGaA engages in the engineering, procurement, and construction of electrochemical plants in Germany, Italy, Japan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NCH2 from our risk checks.
thyssenkrupp nucera AG & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.94 |
| 52 Week High | €25.28 |
| 52 Week Low | €11.55 |
| Beta | 0 |
| 1 Month Change | -18.22% |
| 3 Month Change | -19.97% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.23% |
Recent News & Updates
Shareholder Returns
| NCH2 | DE Construction | DE Market | |
|---|---|---|---|
| 7D | 2.1% | -4.3% | 2.0% |
| 1Y | n/a | 29.2% | 2.0% |
Return vs Industry: Insufficient data to determine how NCH2 performed against the German Construction industry.
Return vs Market: Insufficient data to determine how NCH2 performed against the German Market.
Price Volatility
| NCH2 volatility | |
|---|---|
| NCH2 Average Weekly Movement | 5.6% |
| Construction Industry Average Movement | 5.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: NCH2's share price has been volatile over the past 3 months.
Volatility Over Time: NCH2's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1960 | 765 | Werner Ponikwar | thyssenkrupp-nucera.com |
thyssenkrupp nucera AG & Co. KGaA engages in the engineering, procurement, and construction of electrochemical plants in Germany, Italy, Japan, China, and internationally. The company offers green hydrogen, chlor- alkali, and hydrochloric acid solutions. It serves chemical and steel industries, as well as refineries.
thyssenkrupp nucera AG & Co. KGaA Fundamentals Summary
| NCH2 fundamental statistics | |
|---|---|
| Market cap | €1.51b |
| Earnings (TTM) | €16.80m |
| Revenue (TTM) | €706.30m |
89.8x
P/E Ratio2.1x
P/S RatioIs NCH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NCH2 income statement (TTM) | |
|---|---|
| Revenue | €706.30m |
| Cost of Revenue | €615.40m |
| Gross Profit | €90.90m |
| Other Expenses | €74.10m |
| Earnings | €16.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 12.87% |
| Net Profit Margin | 2.38% |
| Debt/Equity Ratio | 0% |
How did NCH2 perform over the long term?
See historical performance and comparison